report_lead_image_with_gradient.png
2023

Cardiovascular Disease & Heart Health VC Market Snapshot

Download this Report
To download this report, please complete the form below

Cardiovascular disease startups get to heart of the matter
Cardiovascular disease is the leading cause of death globally, but new innovations offer promising paths to improve heart health, as our latest VC market snapshot explores. Eyeing a market worth more than $300 billion, cardiovascular disease & heart health startups have raised over $20 billion in VC funding since 2020.

  • A new class of weight loss drugs is targeting a massive market, but incumbents present a formidable obstacle for startups.

  • A majority of VC funding is going toward startups whose most advanced product is in Phase 2 trials.

  • Areas of opportunity include AI detection of vascular disease, digital hypertension management, and surgical tech for outpatient cardiac procedures.


Table of contents
Introduction 3
Cardiovascular disease & heart health VC ecosystem market map 5
VC activity 7
Opportunities 11
Risks and considerations 16
Market segmentation 17